Spanish government's generics campaign criticised by local pharma

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.412, 2003-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spanish sales of generics not on target yet

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 301, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

An average 19.8% increase in the price of generics has been approved by the Indonesian government

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 316, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Plan to curb Spanish pharma spending to save millions

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 276, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The US government's plans to end the pay-for-delay agreements between pharmaceutical and generic companies has been criticised

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 623, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

US pharma industry fears government price controls

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 261, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite